title: Regulation of PP2A by Sphingolipid Metabolism and Signaling.
abstract: Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that is a primary regulator of cellular proliferation through targeting of proliferative kinases, cell cycle regulators, and apoptosis inhibitors. It is through the regulation of these regulatory elements that gives PP2A tumor suppressor functions. In addition to mutations on the regulatory subunits, the phosphatase/tumor suppressing activity of PP2A is also inhibited in several cancer types due to overexpression or modification of the endogenous PP2A inhibitors such as SET/I2PP2A. This review focuses on the current literature regarding the interactions between the lipid signaling molecules, selectively sphingolipids, and the PP2A inhibitor SET for the regulation of PP2A, and the therapeutic potential of sphingolipids as PP2A activators for tumor suppression via targeting SET oncoprotein.
authors: Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina , Charleston, SC , USA.
authors: Joshua
authors: J
authors: Oaks
authors: Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina , Charleston, SC , USA.
authors: Besim
authors: B
authors: Ogretmen
keywords: FTY720; PP2A; ceramide; sphingolipids; tumor suppression
references: Biochem Biophys Res Commun. 1999 Jun 7;259(2):471-5
references: 10362532
references: PLoS One. 2013 Oct 01;8(10):e75292
references: 24098375
references: J Am Soc Nephrol. 1998 Oct;9(10):1873-80
references: 9773788
references: Oncogene. 1995 May 4;10(9):1739-48
references: 7753551
references: FEBS Lett. 1997 Nov 24;418(1-2):179-82
references: 9414122
references: FEBS Lett. 2012 Sep 21;586(19):3159-65
references: 22796192
references: Neurobiol Aging. 2013 Jul;34(7):1748-58
references: 23374587
references: Cell Death Differ. 2008 Jan;15(1):161-70
references: 17962813
references: Cancer Cell. 2005 Nov;8(5):355-68
references: 16286244
references: Blood. 2011 Jun 16;117(24):6660-8
references: 21490338
references: Med Oncol. 2013;30(3):684
references: 23925667
references: Proteomics. 2005 Mar;5(4):1024-32
references: 15712240
references: Mol Med Rep. 2013 May;7(5):1376-80
references: 23467938
references: PLoS One. 2014 Jul 22;9(7):e103033
references: 25050888
references: EMBO Mol Med. 2013 Jan;5(1):105-21
references: 23180565
references: J Virol. 1994 Mar;68(3):1675-81
references: 8107228
references: J Biol Chem. 2010 Aug 27;285(35):26825-31
references: 20558741
references: Biochem J. 2001 Feb 1;353(Pt 3):417-39
references: 11171037
references: Blood. 2008 Jan 1;111(1):275-84
references: 17761520
references: Cancer Cell. 2013 Jan 14;23(1):107-20
references: 23273921
references: Science. 1993 Mar 19;259(5102):1769-71
references: 8456305
references: Jpn J Cancer Res. 2001 Jun;92(6):680-7
references: 11429058
references: J Biol Chem. 1996 May 10;271(19):11059-62
references: 8626647
references: Mol Cell Biol. 1992 Aug;12(8):3346-55
references: 1630450
references: Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9285-90
references: 9256474
references: Mol Cell Biol. 1997 Mar;17(3):1692-701
references: 9032296
references: Blood. 2013 Sep 12;122(11):1923-34
references: 23926298
references: Hepatogastroenterology. 2013 Jun;60(124):669-72
references: 24046827
references: Mol Cell. 2011 Mar 18;41(6):636-48
references: 21419339
references: Biomarkers. 2014 Feb;19(1):70-6
references: 24369732
references: FEBS Lett. 2011 Sep 2;585(17):2653-9
references: 21806989
references: Tumour Biol. 2014 Feb;35(2):1123-8
references: 24014087
references: J Mol Biol. 1999 Jul 9;290(2):547-57
references: 10390352
references: PLoS One. 2012;7(12):e51242
references: 23251465
references: J Lipid Res. 2004 Mar;45(3):496-506
references: 14657198
references: Proc Natl Acad Sci U S A. 1988 Mar;85(6):1768-71
references: 3126494
references: J Biol Chem. 1993 Jul 25;268(21):15523-30
references: 8393446
references: Int J Cancer. 2004 Sep 10;111(4):501-7
references: 15239126
references: BMC Biochem. 2009 Apr 09;10:10
references: 19358706
references: FASEB J. 2009 Mar;23(3):751-63
references: 19028839
references: Med Oncol. 2013 Jun;30(2):524
references: 23471718
references: Cell. 2007 Jul 13;130(1):51-62
references: 17632056
references: Cancer Biol Ther. 2013 Oct 1;14 (10 ):962-72
references: 24025258
references: Cancer Metastasis Rev. 2011 Dec;30(3-4):567-76
references: 22005951
references: Nucleic Acids Res. 2012 Jan;40(1):75-87
references: 21911363
references: Blood. 2011 Oct 13;118(15):4150-8
references: 21844565
references: J Lipid Res. 2012 Aug;53(8):1513-21
references: 22615346
references: Leuk Res. 2011 Jan;35(1):133-5
references: 20943269
references: Tumour Biol. 2013 Aug;34(4):2309-13
references: 23568706
references: Mol Biol Cell. 2007 Apr;18(4):1233-41
references: 17229885
references: Cell. 2001 Jan 12;104(1):119-30
references: 11163245
references: J Biol Chem. 1994 Jan 21;269(3):2258-62
references: 8294483
references: Cancer Res. 2010 Jul 1;70(13):5438-47
references: 20551067
references: Br J Clin Pharmacol. 2004 May;57(5):586-91
references: 15089811
references: J Biol Chem. 1999 Jul 16;274(29):20313-7
references: 10400653
references: Leuk Res. 2003 Aug;27(8):709-17
references: 12801529
references: Biochem J. 1988 Nov 15;256(1):283-90
references: 2851982
references: Cancer Res. 2005 Jun 1;65(11):4578-86
references: 15930275
references: Blood. 2014 Oct 2;124(14 ):2223-34
references: 25082878
references: Int J Cancer. 2006 Nov 1;119(9):2119-26
references: 16823850
references: Pathol Oncol Res. 2014 Apr;20(2):399-407
references: 24163288